SCHEMBL7416251

SCHEMBL7416251

O=C(O)c1ccc2c3c(n(Cc4ccccc4Cl)c2c1)C(=O)CCC3

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 3/20 0.54
HSD17B10 Q99714 3/20 0.54
HPGD P15428 2/20 0.54
FABP4 P15090 1/20 0.54
TSHR P16473 1/20 0.54
DPP4 P27487 4/20 0.44
CCR2 P41597 1/20 0.43
PTPN11 Q06124 1/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
SLC22A12 Q96S37 1/20 0.41
TP53 P04637 1/20 0.41
CREBBP Q92793 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
AKR1B10 O60218 2/20 0.41
AKR1A1 P14550 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424979 0.94 FABP4 (0.51) ALDH1A1KDM4EHSD17B10HPGDFABP4
SCHEMBL7423051 0.91 DPP4 (0.45) ALDH1A1KDM4EHSD17B10HPGDFABP4
SCHEMBL7422984 0.88 DPP4 (0.47) ALDH1A1KDM4EHSD17B10HPGDFABP4
SCHEMBL7422336 0.85 FABP4 (0.57) ALDH1A1KDM4EHSD17B10HPGDFABP4
SCHEMBL7371603 0.84 ALDH1A1 (0.58) ALDH1A1KDM4EHSD17B10HPGDFABP4
SCHEMBL7467571 0.84 DPP4 (0.44) ALDH1A1FABP4DPP4CCR2LMNA
SCHEMBL7426960 0.84 ALDH1A1 (0.51) ALDH1A1KDM4EHSD17B10HPGDFABP4
SCHEMBL7470778 0.82 DPP4 (0.46) ALDH1A1KDM4EHPGDDPP4MAPK1
SCHEMBL7423222 0.81 DPP4 (0.44) ALDH1A1KDM4EHSD17B10HPGDDPP4
SCHEMBL7418839 0.81 FABP4 (0.54) ALDH1A1FABP4DPP4CCR2PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed